Bilateral retinoblastoma: Clinical presentation, management and treatment

International Ophthalmology

Volumn 33, Issue 5, 2013, Pages 589-593

  Pichi, Francesco ^a   Lembo, Andrea ^a   De Luca, Mariacarla ^b   Hadjistilianou, Theodora ^b   Nucci, Paolo ^a  

^a University Eye Clinic   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Enucleation; Intravenous chemotherapy; Retinoblastoma

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE;

ARTICLE; BILATERAL RETINOBLASTOMA; CANCER CLASSIFICATION; CASE REPORT; CHOROID DISEASE; CONVERGENT STRABISMUS; DNA DETERMINATION; ECHOGRAPHY; ENUCLEATION; EYE EXAMINATION; EYE TUMOR; FEMALE; GHANA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LEUKOKORIA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; RETINA DETACHMENT; RETINOBLASTOMA; SECONDARY GLAUCOMA; TUMOR INVASION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; ETOPOSIDE; EYE ENUCLEATION; FEMALE; HUMANS; IFOSFAMIDE; INFANT; RETINAL NEOPLASMS; RETINOBLASTOMA; TREATMENT OUTCOME;

EID: 84890208309     PISSN: 01655701     EISSN: 15732630     Source Type: Journal    
DOI: 10.1007/s10792-012-9703-5     Document Type: Article

References (27)

1. Shields CL, Shields JA (2006) Basic understanding of current classification and management of retinoblastoma. Curr Opin Ophthalmol 17:228-234
2. Shields JA, Shields CL (2008) Retinoblastoma. In: Shields JA, Shields CL (eds) Atlas of Intraocular Tumors. Lipincott Williams Wilkins, Philadelphia, pp 293-365
3. Shields JA, Shields CL (1992) Management and prognosis of retinoblastoma. Intraocular tumors: a text and atlas. WB Saunders, Philadelphia, pp 377-392
4. Epstein J, Shields CL, Shields JA (2003) Trends in the management of retinoblastoma; Evaluation of 1,196 consecutive eyes during 1974-2001. J Pediatr Ophthalmol Strab 40:196-203 (Pubitemid 36890542)
5. Shields CL, Meadows AT, Leahey AM, Shields JA (2004) Continuing challenges in the management of retinoblastoma with chemoreduction. Retina 24:849-862 (Pubitemid 39657480)
6. Shields CL, Honavar SG, Shields JA, Demirci H, Meadows AT, Naduvilath TJ (2002) Factors predictive of recurrence of retinal tumor, vitreous seeds and subretinal seeds following chemoreduction for retinoblastoma. Arch Ophthalmol 120:460-464 (Pubitemid 34727817)
7. Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh AD, Friedman D, Naduvilaths TJ (2002) Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation. Am J Ophthalmol 133:657-664 (Pubitemid 34462014)
8. Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA (2004) Chemoreduction for retinoblastoma analysis of tumor control and risks for recurrence in 457 tumors. Am J Ophthalmol 138:329-337 (Pubitemid 39208559)
9. Murphree AL (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18(1):41-53 (Pubitemid 40348809)
10. Shields CL, Mashayekhi A, Au AK, Czyz C, Leahey A, Meadows AT, Shields JA (2006) The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology 113:2276-2280 (Pubitemid 44838917)
11. Zigiotti GL, Cavarretta S, Morara M, Nam SM, Ranno S, Pichi F, Lembo A, Lupo S, Nucci P, Meduri A (2012) Standard enucleation with aluminium oxide implant (bioceramic) covered with patient's sclera. Sci World J 2012:481584. doi: 10.1100/2012/481584
12. Karcioglu ZA, Hadjistilianou T (2004) Ocular tumors. In: Karcioglu ZA (ed) Orbital tumors - diagnosis and treatment. Springer, New York, pp 257-265
13. Knudson AG Jr (1974) Heredity and human cancer. Am J Pathol 77(1):77-84
14. DePotter P, Shields CL, Shields JA (1994) Clinical variations of trilateral retinoblastoma: a report of 13 cases. J Pediatr Ophthalmol Strabismus 31:26-31 (Pubitemid 24109496)
15. Shields CL, Meadows AT, Shields JA et al (2001) Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma). Arch Ophthalmol 119:1269-1272 (Pubitemid 32994870)
16. Moll AC, Imhof SM, Schouten-Van Meeteren AY et al (2003) Chemoreduction for retinoblastoma. Arch Ophthalmol 121:1513 (Pubitemid 37243769)
17. Uusitalo MS, Van Quill KR, Scott IU et al (2001) Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination. Arch Ophthalmol 119:41-48 (Pubitemid 32096384)
18. Honavar SG, Singh AD, Shields CL et al (2002) Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 120:923-931 (Pubitemid 34755545)
19. Eagle RC Jr (2009) High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med 133:1203-1209
20. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN (1996) Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 114:1339-1343 (Pubitemid 26398719)
21. Gallie BL, Budning A, DeBoer G et al (1996) Chemotherapy with focal therapy can cure intraocular retinoblastoma without radiotherapy. Arch Ophthalmol 114:1321-1328 (Pubitemid 26398717)
22. Murphree AL, Villablanca JG, Deegan WF III et al (1996) Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol 114:1348-1356 (Pubitemid 26398720)
23. Shields CL, De Potter P, Himelstein BP et al (1996) Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 114:1330-1338 (Pubitemid 26398718)
24. Shields CL, Shields JA (2002) Chemotherapy for retinoblastoma. Editor Med Ped Oncol 38:377-378 (Pubitemid 34507279)
25. Shields CL, Shields JA (2004) Changing management of retinoblastoma. Clin Expiment Ophthalmol 32:345-346 (Pubitemid 39193847)
26. Shields JA, Shields CL, Meadows AT (2005) Chemoreduction in the management of retinoblastoma. Am J Ophthalmol 140:505-506 (Pubitemid 41224843)
27. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C et al (2007) The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol 29(10):700-704 (Pubitemid 47549182)